Patents by Inventor Igal Gery

Igal Gery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
    Publication number: 20220135692
    Abstract: The present invention relates to a conjugate that specifically targets a calcineurin inhibitor to T cells, such as Th17 cells, for use in a method for the treatment of an inflammatory disease. The invention also relates to a method for treating an inflammatory disease by administering a conjugate that specifically targets a calcineurin inhibitor to T cells, such as Th17 cells. In addition, the invention relates to a method for identifying a subject likely to be resistant to steroid treatment, as well as a subject likely to benefit from treatment with a calcineurin inhibitor.
    Type: Application
    Filed: November 24, 2021
    Publication date: May 5, 2022
    Inventors: Richard LEE, Andrew DICK, Lauren SCHEWITZ BOWERS, Robert NUSSENBLATT, Igal GERY, Lai WEI
  • CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
    Publication number: 20200231685
    Abstract: The present invention relates to a conjugate that specifically targets a calcineurin inhibitor to T cells, such as Th17 cells, for use in a method for the treatment of an inflammatory disease. The invention also relates to a method for treating an inflammatory disease by administering a conjugate that specifically targets a calcineurin inhibitor to T cells, such as Th17 cells. In addition, the invention relates to a method for identifying a subject likely to be resistant to steroid treatment, as well as a subject likely to benefit from treatment with a calcineurin inhibitor.
    Type: Application
    Filed: December 20, 2019
    Publication date: July 23, 2020
    Inventors: Richard LEE, Andrew Dick, Lauren Schewitz Bowers, Robert Nussenblatt, Igal Gery, Lai Wei
  • CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
    Publication number: 20160333100
    Abstract: The present invention relates to a conjugate that specifically targets a calcineurin inhibitor to T cells, such as Th17 cells, for use in a method for the treatment of an inflammatory disease. The invention also relates to a method for treating an inflammatory disease by administering a conjugate that specifically targets a calcineurin inhibitor to T cells, such as Th17 cells. In addition, the invention relates to a method for identifying a subject likely to be resistant to steroid treatment, as well as a subject likely to benefit from treatment with a calcineurin inhibitor.
    Type: Application
    Filed: December 19, 2014
    Publication date: November 17, 2016
    Inventors: Richard LEE, Andrew DICK, Lauren SCHEWITZ BOWERS, Robert NUSSENBLATT, Igal GERY, Lai WEI
  • Methods and compositions for the treatment of uveitis
    Patent number: 8895521
    Abstract: Pharmaceutical compositions are disclosed that are of use for the treatment of uveitis. These compositions include a suppressive oligonucleotide. These compositions including an immunosuppressive oligonucleotide can be used for the treatment of uveitis, including anterior, posterior, and diffuse uveitis.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: November 25, 2014
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Dennis M. Klinman, Igal Gery, Chiaki Fujimoto
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF UVEITIS
    Publication number: 20090082288
    Abstract: Pharmaceutical compositions are disclosed that are of use for the treatment of uveitis. These compositions include a suppressive oligonucleotide. These compositions including an immunosuppressive oligonucleotide can be used for the treatment of uveitis, including anterior, posterior, and diffuse uveitis.
    Type: Application
    Filed: May 5, 2005
    Publication date: March 26, 2009
    Applicant: THE GOVERNMENT OF THE U.S. OF AMERICA AS REPRESENTED BY THE SECRETARY OF DEPT OF HEALTH
    Inventors: Dennis M. Klinman, Igal Gery, Chiaki Fujimoto